梅州治疗白癜风的权威机构-【汕头中科白癜风医院】,汕头中科白癜风医院,白癜风梅州哪家比较好,普宁哪有白癜风遮盖机构,潮州去白癜风哪家好吗,白癜风软膏汕头后保存多久,普宁治疗白癜风最佳时间,梅州白癜风手术费用多少

As the counting of ballots continue, one trend is emerging: the final result will be close. A potential consequence of that will be a recount. Perhaps in one state or in multiple states. RECOUNT RULESEach state handles recounts differently. For example, in Arizona, an automatic recount is triggered if the margin between candidates is less than or equal to 0.1 percent of the votes cast. In Georgia, candidates can request recounts if the margin is no more than .5 percent of total votes cast.DO RECOUNTS CHANGE ANYTHINGAccording to FairVote.org, recounts rarely change races. Since 1980, there have been 5,778 statewide elections.There have only been 31 completed statewide recounts.Only three have been overturned because of a recount.Perhaps the most famous recount of all was in Florida in 2000.But the 2000 Florida Recount only shifted the final margins by 1,247 votes or 0.02%In a recount in Wisconsin in the 2016 Presidential race, the final margin only changed by 571 votes. "I believe recounts in themselves are not in favor of those who have lost a race unless it's a very close margin," Dr. Eric Claville, a political scientist with Norfolk State University said. 1183
AUSTIN, Texas — For Brett Hagler, the co-founder of non-profit New Story, building homes for people without adequate shelter is nothing new."We get a large piece of land and work with families that have been living in shacks or tents without shelter and design a totally new community with the families.”Approximately one billion of the world’s population is without proper shelter.To make a dent in that he says, they have to think outside the mold.“We believe traditional ways cannot get us there.”So for New Story’s next endeavor—adding more communities to the land they’ve already acquired in El Salvador—they teamed up with a brand new startup.That’s where Evan Loomis comes in. He’s the co-founder of Austin, Texas-based Icon, a company focused on new technologies for building homes.Their first big debut came at this year’s South by Southwest festival in their hometown.“This is a gigantic robot,” Loomis says, gesturing toward a large steel frame on wheels. “[It] really does some amazing things. Down to the millimeter it knows exactly where to place building materials.”In this case that material is a proprietary mixture of concrete, that pours out of a nozzle on the underside of the metalwork. And the machine moves along a computerized map to create a house.“This is basically the first permitted 3D printed house in the United States,” he said.“We have to invest in [research and design],” Hagler said. “[We asked ourselves] ‘how do we get a breakthrough in cost, speed, and quality?’ And that’s how we landed upon 3D-home printing. The excitement in the air is palpable as they walk us through and around this modest home built up of about 100 one-inch thick concrete layers.“It’s stronger than regular cinder block,” Hagler said. It also comes at a fraction of the cost of a regular house. This model had a price tag of about ,000 but they hope to get the price down to ,000.“We can build in a fraction of the time [compared to traditional construction methods], and it can have a higher quality, strength, and sustainability for the environment."It was 'printed' in just 48 hours. Eventually, they say it will be done in just a half day. It’s a small but open floor plan — with no physical doors — and rooms are separated by partial walls made up of the printed concrete.They say they’ll easily be able to customize different designs.The prototype home can fit a family of four or five.“If you’re coming from a tent or shack and you move into this,” Hagler said, “it’s a significant life-changing difference.”One of the things they’re most excited about with their upcoming 3D-homes project in El Salvador is the fact that they’re introducing groundbreaking technology to the people who usually see tech advances last.“We are actually bringing them the future -- which is robotic construction of housing — first,” Hagler said. “And they’re really excited about that.”They say they plan to begin construction in El Salvador before the end of the year with the hopes of finishing their first community of homes by early 2019. There could one day be plans for 3D printed homes in some of the poorest areas of the United States as well, Loomis said, but he has his eye set on possibly expanding to terrain that’s literally out of this world.“It could be a really great solution for making space habitation a lot more achievable,” Loomis said. “We hit a nerve with this technology, and we are going to hit the gas hard and try to take it to everybody now.” 3528

At a rally on Sunday, President Donald Trump said that he might fire Dr. Anthony Fauci, his administration's top infectious disease expert, shortly after Tuesday's election.At a rally in Opa-Locka, Florida on Sunday, supporters broke into a "Fire Fauci!" chant as Trump discussed the COVID-19 pandemic."Don't tell anyone, but let me wait 'til a little bit after the election," Trump said.The comments marked the first time that Trump has publicly indicated that he may fire Fauci, who has been the head of the National Institute for Allergies and Infectious Diseases since 1984.Fauci, a member of the White House's corornavirus task force, has consistently been the most plain-spoken Trump administration official when speaking about the challenges the country faces amid the pandemic.Trump has publicly criticized Fauci throughout the pandemic. In October, with COVID-19 cases on the rise, Trump tweeted an attack on Fauci. Days later, during a campaign call, Trump called Fauci a "disaster" and said he and other health experts were "idiots."Polling has shown that Americans consistently believe that they trust Fauci more than Trump when it comes to handling COVID-19.In the past, Fauci has implied that the White House has limited the number of media appearances he can make, and has also said an ad by the Trump campaign took him out of context. 1358
AstraZeneca is the latest drugmaker to announce promising Phase 3 trial results from its COVID-19 vaccine candidate.On Monday, AstraZeneca said its two-shot vaccine candidate has been 90% effective thus far along with no safety concerns.“These findings show that we have an effective vaccine that will save many lives," said Professor Andrew Pollard, the chief executive of the study. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply. Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.”The company added in its press release that its vaccine candidate offers two distinct advantages over vaccines made by Pfizer and Moderna — it's cheaper to produce, and does not need to be stored in ultra-cold conditions before use.AstraZeneca added that the company would "immediately" prepare regulatory paperwork to seek Emergency Use Listing status from the World Health Organization.AstraZeneca is just the latest drug company to report encouraging results from its COVID-19 vaccine candidate.Last week, Pfizer said it had submitted Emergency Use Authorization paperwork to the Food & Drug Administration (FDA) after a final analysis of its vaccine candidate proved to be 95% effective in preventing COVID-19. The FDA is expected to approve the drug in the coming weeks.Moderna has also said that early results show its vaccine candidate to be 95% effective, and is on track to have the drug approved for Emergency Use Authorization by the end of the year.AstraZeneca, Pfizer and Moderna are all shattering records for vaccine development. The three vaccines are all on track to be approved for widespread use in uder a year. Typically, it takes several years for a vaccine to go from development to approval.The announcement comes as COVID-19 is spreading around the world at a rate not previously seen since the pandemic began. And while all three companies are pre-producing their vaccines in the hope that it will be approved, health experts warn that they won't be widely available until spring 2021. 2247
BALTIMORE — A doctor described as providing care to the "sickest patients" in Baltimore died of COVID-19, Mercy Medical Center said in a Facebook post.Dr. Joseph J. Costa, the chief of critical care at the hospital, was 56 years old."Joe was more than a trusted colleague; he was also a true friend to many. He dedicated his life and career to caring for the sickest patients. And when the global pandemic came down upon us, Joe selflessly continued his work on the front lines—deeply committed to serving our patients and our City during this time of great need. His memory will live on as an example to us all," the hospital said in a Facebook post.Costa joined Mercy in 1997 and became Chief of Critical Care in 2005. From 2010 to 2016 he served as an officer of the Mercy Medical Staff, culminating with his 2-year tenure as President of the Medical Staff."Joe was admired and respected among providers throughout the Baltimore region for his clinical expertise. He was beloved by his patients and their family members—known for his warm and comforting bedside manner as well as his direct and informative communication style. When he counseled our patients and families, he did so with great compassion and empathy. For all the nurses and staff who worked closely with Joe on the Intensive Care Unit, he was like an older brother that all admired and revered," the post continued.Read the full letter below. Dear Friends of Mercy, It is with great sadness that we mourn the loss of Joseph J. Costa, M.D., Chief, Division of...Posted by Mercy Medical Center, Baltimore, MD on Saturday, July 25, 2020 This story was originally published by Brandon Ingram on WMAR in Baltimore. 1702
来源:资阳报